Equillium (EQ) Other Operating Expenses (2018 - 2025)

Equillium (EQ) posted quarterly Other Operating Expenses of $901000.0 for Q3 2025, down 96.09% quarter-over-quarter from $23.0 million in Q1 2022.

Equillium (EQ) Other Operating Expenses (2018 - 2025) Analysis & Trends

Equillium (EQ) has reported Other Operating Expenses for 3 consecutive years, with $901000.0 the latest figure, recorded in Q3 2025.

In Q3 2025, Other Operating Expenses changed N/A year-over-year to $901000.0; the TTM figure through Sep 2025 stood at $901000.0 (changed N/A YoY), while the FY2022 annual figure was $23.0 million, changed N/A from the prior year.
Other Operating Expenses slipped to $901000.0 in Q3 2025 per EQ's latest filing, from $23.0 million in the prior quarter.
Across five years, Other Operating Expenses topped out at $23.0 million in Q1 2022 and bottomed at $901000.0 in Q3 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Vertex Pharmaceuticals	128.13 Bn	120.28 Bn	2.84 Bn
2	Regeneron Pharmaceuticals	112.33 Bn	104.33 Bn	3.93 Bn
3	Argenx Se	53.24 Bn	48.05 Bn	1.41 Bn
4	Revolution Medicines	43.64 Bn	43.64 Bn	-
5	BeOne Medicines	39.27 Bn	34.17 Bn	1.53 Bn
6	MindWalk Holdings	35.32 Bn	35.31 Bn	1.82 Bn
7	Royalty Pharma	33.72 Bn	35.84 Bn	-
8	Alnylam Pharmaceuticals	30.58 Bn	27.27 Bn	992.69 Mn
9	Insmed	27.01 Bn	25.85 Bn	358.27 Mn
10	Equillium	263.86 Mn	263.86 Mn	-

Download Data